BioSig Technologies, Inc. (BSGM) DCF Valuation

BioSig Technologies, Inc. (BSGM) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

BioSig Technologies, Inc. (BSGM) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Gain insight into your BioSig Technologies, Inc. (BSGM) valuation analysis using our cutting-edge DCF Calculator! This Excel template comes preloaded with real BSGM data, enabling you to adjust forecasts and assumptions to accurately determine the intrinsic value of BioSig Technologies, Inc.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .4 .3 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 -35.15 -93.71 -32.21 -32.21 -32.21 -32.21 -32.21
EBITDA -34.4 -58.6 -33.2 -27.0 -28.2 .0 .0 .0 .0 .0
EBITDA, % 100 100 -7531.29 -9430.77 -156394.44 -20 -20 -20 -20 -20
Depreciation .1 .6 .6 .7 .4 .0 .0 .0 .0 .0
Depreciation, % 100 100 144.9 232.87 2005.56 100 100 100 100 100
EBIT -34.5 -59.2 -33.9 -27.6 -28.5 .0 .0 .0 .0 .0
EBIT, % 100 100 -7676.19 -9663.64 -158400 -20 -20 -20 -20 -20
Total Cash 12.1 28.3 11.7 .5 .2 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 0 3.15 133.33
Inventories .6 .8 1.9 .3 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 426.53 117.48 0 80 80 80 80 80
Accounts Payable .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 0 0 0 40 40 40 40 40
Capital Expenditure -.3 -.1 -.5 -.2 -.2 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 -122.9 -58.74 -1033.33 -51.75 -51.75 -51.75 -51.75 -51.75
Tax Rate, % -1.22 -1.22 -1.22 -1.22 -1.22 -1.22 -1.22 -1.22 -1.22 -1.22
EBITAT -33.9 -52.2 -32.3 -27.6 -28.9 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -34.7 -51.9 -33.3 -25.6 -28.4 .0 .0 .0 .0 .0
WACC, % 6.05 6.03 6.04 6.05 6.05 6.04 6.04 6.04 6.04 6.04
PV UFCF
SUM PV UFCF .0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt 0
Equity Value 0
Diluted Shares Outstanding, MM 7
Equity Value Per Share -0.03

What You Will Receive

  • Comprehensive Financial Model: BioSig Technologies' actual data provides an accurate DCF valuation.
  • Complete Forecasting Control: Modify revenue growth, profit margins, WACC, and other essential drivers.
  • Real-Time Calculations: Automatic updates allow you to view results immediately as you adjust parameters.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation presentations.
  • Flexible and Reusable: Designed for adaptability, enabling repeated use for in-depth forecasts.

Key Features

  • Cutting-Edge Signal Processing Technology: Leverages advanced algorithms for precise cardiac signal analysis.
  • Comprehensive Data Analytics: Offers in-depth insights into cardiac procedures with customizable reporting tools.
  • User-Friendly Interface: Intuitive design allows for easy navigation and efficient data management.
  • Real-Time Monitoring: Provides instant feedback during procedures to enhance patient outcomes.
  • Robust Compliance Features: Ensures adherence to industry regulations and standards for medical devices.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered BioSig Technologies data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for BioSig Technologies’ intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for BioSig Technologies, Inc. (BSGM)?

  • Designed for Experts: A sophisticated tool tailored for healthcare analysts, financial officers, and industry consultants.
  • Comprehensive Data: BioSig's historical and projected financial data preloaded for enhanced precision.
  • Flexible Scenario Analysis: Effortlessly test various forecasts and assumptions to gauge potential outcomes.
  • Insightful Results: Automatically computes intrinsic value, NPV, and essential financial metrics.
  • User-Friendly: Step-by-step guidance ensures a smooth and straightforward experience.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling BioSig Technologies stock (BSGM).
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models specific to BioSig Technologies (BSGM).
  • Consultants: Deliver professional valuation insights for BioSig Technologies (BSGM) to clients quickly and accurately.
  • Business Owners: Understand how innovative companies like BioSig Technologies (BSGM) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to BioSig Technologies (BSGM).

What the Template Contains

  • Pre-Filled Data: Includes BioSig Technologies, Inc.'s (BSGM) historical financials and projections.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze BioSig Technologies, Inc.'s (BSGM) profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.